These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 4391786

  • 1. Regional distribution and metabolism of H3-tyramine in the rat brain.
    Goldstein M, Anagnoste B, Yamamoto A, Felch WC.
    J Pharmacol Exp Ther; 1970 Feb; 171(2):196-204. PubMed ID: 4391786
    [No Abstract] [Full Text] [Related]

  • 2. The metabolism of tyramine-H3 in different regions of the CNS.
    Anagnoste B, Goldstein M.
    Life Sci; 1967 Jul 15; 6(14):1535-40. PubMed ID: 4382651
    [No Abstract] [Full Text] [Related]

  • 3. Metabolism of tyramine-3H and octopamine-3H by rat brain.
    Breese GR, Chase TN, Kopin IJ.
    Biochem Pharmacol; 1969 Apr 15; 18(4):863-9. PubMed ID: 4389230
    [No Abstract] [Full Text] [Related]

  • 4. Identification and distribution of m- and p-hydroxyphenylacetic acids in the brain of the rat.
    Durden DA, Boulton AA.
    J Neurochem; 1981 Jan 15; 36(1):129-35. PubMed ID: 7463042
    [Abstract] [Full Text] [Related]

  • 5. Accumulation and disappearance of 3 H-5-hydroxytryptamine formed in vivo from 3 H-tryptophan in various regions of the rat brain.
    Schubert J, Sedvall G.
    Eur J Pharmacol; 1972 Jan 15; 17(1):75-80. PubMed ID: 5016584
    [No Abstract] [Full Text] [Related]

  • 6. Effects of chlorpromazine on the metabolism of catecholamines in dog brain.
    Guldberg HC, Yates CM.
    Br J Pharmacol; 1968 Sep 15; 34(1):220P. PubMed ID: 5676021
    [No Abstract] [Full Text] [Related]

  • 7. Effect of L-DOPA on the synthesis and excretion of tyramine.
    Boulton AA, Wu PH.
    Adv Neurol; 1974 Sep 15; 5():119-25. PubMed ID: 4613157
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of dopamine-beta-hydroxylase by disulfiram in vivo.
    Musacchio JM, Goldstein M, Anagnoste B, Poch G, Kopin IJ.
    J Pharmacol Exp Ther; 1966 Apr 15; 152(1):56-61. PubMed ID: 5937402
    [No Abstract] [Full Text] [Related]

  • 10. The normal occurrence of octopamine in the central nervous system of the rat.
    Buck SH, Murphy RC, Molinoff PB.
    Brain Res; 1977 Feb 18; 122(2):281-97. PubMed ID: 13909
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Metabolism of tyramine to dopamine by liver microsomes.
    Lemberger L, Kuntzman R, Conney AH, Burns JJ.
    J Pharmacol Exp Ther; 1965 Nov 18; 150(2):292-7. PubMed ID: 5855884
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 4,4,6-trimethyl-3,4-dihydropyrimidine-2-thiol, an effective inhibitor of dopamine-beta-hydroxylation in vivo.
    Porter CC, Torchiana ML.
    Biochem Pharmacol; 1971 Jan 18; 20(1):183-91. PubMed ID: 4398314
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.